A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment.
A scientist at the University of Birmingham has received a £1.4 million award from Cancer Research UK to carry out pioneering research that may discover how cancer 'steals the keys' from the body's locksmiths, disrupting healthy cell growth and function.
Professor Dion Morton, Director of the Experimental Cancer Medicine Centre at the University of Birmingham, writes for the NIHR Blog on how the NIHR health research system has supported innovative research in his area of cancer surgery.
The College of Medical and Dental Sciences is delighted to announce that at the University of Birmingham Founders' Awards for Excellence 2017, held on Thursday 12 July during the Chancellor's Dinner, colleagues from across the College were awarded three of the evening's four awards.
The National Institute for Health Research (NIHR) has awarded £7 million to the Universities of Birmingham, Edinburgh and Warwick to establish a joint research unit focussed on developing global surgical research.
Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progression of the disease, according to new research by the Universities of Birmingham and Oxford.
Researchers at the University of Birmingham have found that a type of protein could hold the secret to suppressing the growth of breast cancer tumours.
One of the largest clinical trials for prostate cancer led by the University of Birmingham has found that adding Abiraterone to hormone therapy at the start of treatment improves survival by 37%.
A study led by the University of Birmingham has made a breakthrough in the understanding of how different genetic mutations cause acute myeloid leukaemia.
A faster and more accurate method of identifying which of an individual's genes are associated with particular symptoms has been developed by a team of researchers from the UK and Saudi Arabia. This new approach could enable scientists to take advantage of recent developments in genome sequencing to improve diagnosis and potential treatment options.